Vaginal
application of micronized progesterone
Age related risk mscarriage:- Many studies have noticed that during
the age of 20 years the risk of miscarriage was found to be 10% but the prevalence rose rapidly after 30 % and reached 53% in
women aged > 45 .There is a
strong recurrence risk of
miscarriage with an age adjusted
ratio
What
are the advantages of Vaginal application
of progesterone Ans;-Vaginal application
of progesterone results
in a rapid and semi selective effect on the uterus which occurs due to local counter current transfer
from the vaginal vein blood to
the uterine arterial blood . This leads to an induction of greater
concentrations in arterial blood to the uterus or urethra than in other
arteries. The transfer is based on the blood flow and may also involve lymph
vessels.
What
are the effects of vaginal Progesterone?? Ans:-
Actions of
natural micronized progesterone such
as 1) immune modulatory
properties related to positive 2)
regulation of progesterone induced blocking factor , 3) Natural killer cells and
4) protein coding gene modulation supports endometrial implantation.
Serum progesterone
& prediction of continuation of pregancy?? Can we predict possibility implantation or
continuation of early pregancy with late luteal progesterone level ,say day 23/day 24 ? What is the optimum
Progesterone at this stage of stimulated / unstimaulted cycle??
Ans:-1) levels of
< 5 ng/ml were observed to be associated with a spontaneous miscarriage
in 86% of cases 2) but
it becomes only 8% provided serum Progesterone is 20-25 ng/ ml . By and large in normal cycles the level of progesterone is around of
>14 ng/ ml in the mid luteal
phase for maintaining pregnancy ..
How
to prevalence and causes of recurrent
pregnancy loss .
What do we mean by
“The
PROMISE trial in 2015 “
pertaining to relevance of MNP(micronized Progesterone?? “
It (Trial) showed that daily
vaginal progesterone in first trimester do not
increase ongoing pregnancy or live birth rates in women with unexplained RM.
But a recent
study conducted to determine the
effect of administration of
progesterone in the luteal phase
of the cycle demonstrated reduced
risk of miscarriage in women
with history of unexplained recurrent
miscarriage.
No comments:
Post a Comment